|
The Childhood Vaccine Program received notice from the CDC that due to limited supply and high demand of nirsevimab, this product will be paused until further notice. Any orders currently pending will be rejected until the manufacturer makes additional doses available. We expect this product to be under allocation in the coming weeks and can share more information as it develops.
We apologize for any inconvenience and hope to have additional doses available to order in the near future. Thank you for your patience and understanding.
|
